NanoEcho AB (publ) (STO:NANECH)
Sweden · Delayed Price · Currency is SEK 0.0362
0.00 (0.00%)
At close: Jul 23, 2026
NanoEcho AB Revenue
NanoEcho AB had revenue of 290.00K SEK in the quarter ending March 31, 2026, with 126.56% growth. This brings the company's revenue in the last twelve months to 1.50M, down -85.46% year-over-year. In the year 2025, NanoEcho AB had annual revenue of 1.63M, down -78.84%.
Revenue (ttm)
1.50M
Revenue Growth
-85.46%
P/S Ratio
34.57
Revenue / Employee
97.40K
Employees
5
Market Cap
16.84M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.63M | -6.06M | -78.84% |
| Dec 31, 2024 | 7.68M | 5.24M | 214.88% |
| Dec 31, 2023 | 2.44M | 20.00K | 0.83% |
| Dec 31, 2022 | 2.42M | 2.10M | 649.68% |
| Dec 31, 2021 | 322.67K | 321.67K | 32,167.30% |
| Dec 31, 2020 | 1,000.00 | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Magle Chemoswed Holding AB | 273.25M |
| Fluicell AB | 20.15M |
| ExpreS2ion Biotech Holding AB | 16.12M |
| AcouSort AB | 10.05M |
| Aptahem AB | 2.52M |
| Biosergen AB | 2.09M |
| 2cureX AB | 1.98M |
| Pila Pharma AB | 1.13M |
NanoEcho AB News
- 3 months ago - NanoEcho AB Quarterly report: Q1 2026 - Filings
- 5 months ago - NanoEcho AB Annual report: Q4 2025 - Filings
- 5 months ago - NanoEcho AB Quarterly report: Q4 2025 - Filings
- 9 months ago - NanoEcho AB Quarterly report: Q3 2025 - Filings
- 1 year ago - NanoEcho AB Quarterly report: Q2 2025 - Filings